FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation

Int J Lab Hematol. 2024 Apr 10. doi: 10.1111/ijlh.14275. Online ahead of print.

Authors

Song Xue¹, Wenqiu Huang¹, Yongping Zhang¹, Fuhong Liu¹, Qi Hao¹, Jiajun Hu¹, Lei Yuan², Jingbo Wang¹

Affiliations

¹ Department of Hematology, Aerospace Center Hospital, Beijing, China.
² Department of Hematology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.

PMID: 38600651
DOI: 10.1111/ijlh.14275

No abstract available

Publication types

Letter